Summary
The Expanded Newborn Screening Program (MS/MS) in the region of Galicia (NW Spain) was initiated in 2000 and includes the measurement of methionine levels in dried blood spots. Between June 2000 and June 2007, 140 818 newborns were analysed, and six cases of persistent hypermethioninaemia were detected: one homocystinuria due to cystathionine β-synthase (CβS) deficiency, and five methionine adenosyltransferase I/III (MAT I/III) deficiencies. The five cases of MAT I/III deficiency represent an incidence of 1/28 163 newborns. In these five patients, methionine levels in dried blood spots ranged from 50 to 147 μmol/L. At confirmation of the persistence of the hypermethioninaemia in a subsequent plasma sample, plasma methionine concentrations were moderately elevated in 4 of the 5 patients (mean 256 μmol/L), while total homocysteine (tHcy) was normal; the remaining patient showed plasma methionine of 573 μmol/L and tHcy of 22.8 μmol/L. All five patients were heterozygous for the same dominant mutation, R264H in the MAT1A gene. With a diet not exceeding recommended protein requirements for their age, all patients maintained methionine levels below 300 μmol/L. Currently, with a mean of 2.5 years since diagnosis, the patients are asymptomatic and show developmental quotients within the normal range. Our results show a rather high frequency of hypermethioninaemia due to MAT I/III deficiency in the Galician neonatal population, indicating a need for further studies to evaluate the impact of persistent isolated hypermethioninaemia in neonatal screening programmes.
Similar content being viewed by others
Abbreviations
- CβS:
-
cystathionine β-synthase
- MAT I/III:
-
methionine adenosyltransferase I/III
- MS/MS:
-
tandem mass spectrometry
- AdoMet:
-
S-adenosylmethionine
- tHcy:
-
total homocysteine
References
Andria G, Fowler B, Sebastio G (2005) Disorders of sulfur amino acid metabolism. In: Fernández J, Saudubray JM, Van den Berghe G, Walter JH, eds. Inborn Metabolic Diseases, 4th edn. Würzburg: Springer Medizin Verlag, 273–282.
Blom HJ, Davidson AJ, Finkelstein JD, et al (1992) Persistent hypermethioninemia with dominant inheritance. J Inherit Metab Dis 15: 188–197.
Braverman NE, Mudd SH, Barker PB, Pomper MG (2005) Characteristic MR imaging changes in severe hypermethioninemic states. Am J Neuroradiol 26: 2705–2706.
Chamberlin ME, Ubagai T, Mudd SH, Wilson WG, Leonard JV, Chou JY (1996) Demyelination of the brain is associated with methionine adenosyltransferase I/III deficiency. J Clin Invest 98: 1021–1027.
Chamberlin ME, Ubagai T, Mudd SH, Levy HL, Chou JY (1997) Dominant inheritance of isolated hypermethioninaemia is associated with a mutation in the human methionine adenosyltransferase 1A gene. Am J Hum Genet 60: 540–546.
Chamberlin ME, Ubagai T, Mudd SH, et al (2000) Methionine adenosyltransferase I/III deficiency: novel mutations and clinical variations. Am J Hum Genet 66: 347–355.
Chien Y, Chiang S, Huang A, Hwu W (2005) Spectrum of hypermethioninemia in neonatal screening. Early Hum Dev 81: 529–533.
Gahl WA, Bernardini I, Finkelstein JD, et al (1988) Transsulfuration in an adult with hepatic methionine adenosyltransferase deficiency. J Clin Invest 81: 390–397.
Hazelwood S, Bernardini I, Tangerman A, et al (1998) Lack of brain demyelination in a patient homozygous for a mutation encoding a severely truncated methionine adenosyltransferase I/III. Am J Med Genet 75: 395–400.
Hwu WL (2004) Neonatal screening in Taiwan. The 5th Asia Pacific Regional Meeting of the International Society for Neonatal Screening; Shanghai, China.
Ito M, Kotani Y, Matsuda J, et al (2003) A methionine adenosyltransferase (MAT) deficiency patient treated with diet therapy. J Inherit Metab Dis 26(Supplement 2): 76.
Kim SZ, Santamaria E, Jeong TE, et al (2002) Methionine adenosyltransferase I/III deficiency: two Korean compound heterozygous siblings with a novel mutation. J Inherit Metab Dis 25: 661–671.
Linnebank M, Lagler F, Muntau AC, et al (2005) Methionine adenosyltransferase (MAT) I/III deficiency with concurrent hypermethioninemia and hyperhomocysteinemia: two novel cases. J Inherit Metab Dis 28: 1167–1168.
Martins E, Eusebio F, Marcao A, Rocha H, Vilarinho L (2007) Five families with hypermethioninemia associated with the dominantly inherited methionine adenosyltransferase I/III form deficiency. J Inherit Metab Dis 30(Supplement 1): 6.
Mudd SH, Levy HL, Tangerman A, et al (1995) Isolated persistent hypermethioninemia. Am J Hum Genet 57: 882–892.
Mudd SH, Jenden DJ, Capdevila A, Roch M, Levy HL, Wagner C (2000) Isolated hypermethioninemia: measurements of S-adenosylmethionine and choline. Metabolism 49: 1542–1547.
Mudd SH, Levy HL, Kraus JP (2001) Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2007–2056.
Mudd SH, Braverman N, Pomper M, et al (2003) Infantile hypermethioninemia and hyperhomocysteinemia due to high methionine intake: a diagnosis trap. Mol Genet Metab 79: 6–16.
Nagao M, Oyanagi K (1997) Genetic analysis of isolated persistent hypermethioninemia with dominant inheritance. Acta Paediatr Jpn, 39: 601–606.
Perez-Mato I, Sanchez del Pino M, Chamberlin M, Mudd SH, Mato JM, Corrales FJ (2001) Biochemical basis for the dominant inheritance of hypermethioninemia associated with the R264H mutation of the MAT1A gene. J Biol Chem 276: 13803–13809.
Stabler SP, Steegborn C, Wahl MC, et al (2002) Elevated plasma total homocysteine in severe MAT I/III deficiency. Metabolism 51: 981–988.
Surtees R, Leonard J, Austin S (1991) Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway. Lancet 338: 1550–1554.
Tada H, Takanashi JI, Barkovitch AJ, Yamamoto S, Kohno Y (2004) Reversible white matter lesion in methionine adenosyltransferase I/III deficiency. Am J Neuroradiol 25: 1843–1845.
ten Hoedt AE, van Kempen AA, Boelen A, et al (2007) High incidence of hypermethioninaemia in a single neonatal intensive care unit detected by a newly introduced neonatal screening programme. J Inherit Metab Dis 30: 978.
Ubagai T, Lei KJ, Huang S, Mudd SH, Levy HL, Chou JY (1995) Molecular mechanisms of an inborn error of methionine pathway. J Clin Invest 96: 1943–1947.
Wilcken B, Wiley V, Hammond J, Carpenter K (2003) Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med 348: 2305–2312.
Acknowledgements
The authors thank Dr Conrad Wagner for assays of plasma AdoMet and S-adenosylhomocysteine, and Dr Sally Stabler for assay of plasma cystathionine.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Mohamed Rashed
JIMD Short Report #110 (2008) Online
Competing interests: None declared
References to electronic databases: MAT I/III deficiency (OMIM 250850)
Rights and permissions
About this article
Cite this article
Couce, M.L., Bóveda, M.D., Castiñeiras, D.E. et al. Hypermethioninaemia due to methionine adenosyltransferase I/III (MAT I/III) deficiency: Diagnosis in an expanded neonatal screening programme. J Inherit Metab Dis 31 (Suppl 2), 233–239 (2008). https://doi.org/10.1007/s10545-008-0811-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-008-0811-3